A more recent analysis showed that karyotypic clonal fraction (evaluated as low ≤50% clonal cells and high with ≥50% clonal cells) and the presence of CK are determinant factors for predicting adverse outcome of TP53-mutant MDS [18]. Here, TP53 is linked to myelodysplastic syndrome.